Poseida Therapeutics, Inc. Net Income
Poseida Therapeutics, Inc. reported Net Income of $20.23 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2024-11-07
- Poseida Therapeutics, Inc. net income (loss) attributable to parent for the quarter ending 2024-09-30 was $20.23M.
- Poseida Therapeutics, Inc. net income (loss) attributable to parent for the quarter ending 2024-06-30 was -$31.37M.
- Poseida Therapeutics, Inc. net income (loss) attributable to parent for the quarter ending 2024-03-31 was -$24.27M.
- Poseida Therapeutics, Inc. net income (loss) attributable to parent for the quarter ending 2023-12-31 was -$25.35M.
- Poseida Therapeutics, Inc. net income (loss) attributable to parent for fiscal 2023 was -$123.43M.
- Poseida Therapeutics, Inc. net income (loss) attributable to parent for fiscal 2022 was -$64.00M.
- Poseida Therapeutics, Inc. net income (loss) attributable to parent for fiscal 2021 was -$124.97M.
- Poseida Therapeutics, Inc. net income (loss) attributable to parent for fiscal 2020 was -$129.78M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month | Net Income (Loss) Attributable to Parent 12 month as first filed | Net Income (Loss) Attributable to Parent 24 month |
|---|---|---|---|---|---|---|
| 2024-09-30 | $20.23M 10-Q · filed 2024-11-07 | -$11.14M derived: sum of 2 quarters · filed 2024-11-07 | -$35.41M 10-Q · filed 2024-11-07 | -$60.76M derived: sum of 4 quarters · filed 2024-11-07 | ||
| 2024-06-30 | -$31.37M 10-Q · filed 2024-11-07 | -$55.65M 10-Q · filed 2024-08-05 | -$80.99M derived: sum of 3 quarters · filed 2024-11-07 | -$112.77M derived: sum of 4 quarters · filed 2024-11-07 | ||
| 2024-03-31 | -$24.27M 10-Q · filed 2024-11-07 | -$49.62M derived: sum of 2 quarters · filed 2024-11-07 | -$81.40M derived: sum of 3 quarters · filed 2024-11-07 | -$108.86M derived: sum of 4 quarters · filed 2024-11-07 | ||
| 2023-12-31 | -$25.35M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | -$57.13M derived: sum of 2 quarters · filed 2024-11-07 | -$84.58M derived: sum of 3 quarters · filed 2024-11-07 | -$123.43M 10-K · filed 2024-03-07 | ||
| 2023-09-30 | -$31.78M 10-Q · filed 2024-11-07 | -$59.23M derived: sum of 2 quarters · filed 2024-11-07 | -$98.08M 10-Q · filed 2024-11-07 | -$131.40M derived: sum of 4 quarters · filed 2024-11-07 | ||
| 2023-06-30 | -$27.46M 10-Q · filed 2024-11-07 | -$66.30M 10-Q · filed 2024-08-05 | -$99.62M derived: sum of 3 quarters · filed 2024-11-07 | -$29.21M derived: sum of 4 quarters · filed 2024-11-07 | ||
| 2023-03-31 | -$38.85M 10-Q · filed 2024-11-07 | -$72.17M derived: sum of 2 quarters · filed 2024-11-07 | -$1.76M derived: sum of 3 quarters · filed 2024-11-07 | -$44.79M derived: sum of 4 quarters · filed 2024-11-07 | ||
| 2022-12-31 | -$33.32M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $37.09M derived: sum of 2 quarters · filed 2024-03-07 | -$5.95M derived: sum of 3 quarters · filed 2024-03-07 | -$64.00M 10-K · filed 2024-03-07 | ||
| 2022-09-30 | $70.41M 10-Q · filed 2023-11-09 | $27.37M derived: sum of 2 quarters · filed 2023-11-09 | -$30.68M 10-Q · filed 2023-11-09 | -$29.21M derived: sum of 4 quarters · filed 2023-11-09 | ||
| 2022-06-30 | -$43.04M 10-Q · filed 2023-11-09 | -$101.09M 10-Q · filed 2023-08-08 | -$99.62M derived: sum of 3 quarters · filed 2023-11-09 | -$142.05M derived: sum of 4 quarters · filed 2023-11-09 | ||
| 2022-03-31 | -$58.06M 10-Q · filed 2023-11-09 | -$56.59M derived: sum of 2 quarters · filed 2023-11-09 | -$99.01M derived: sum of 3 quarters · filed 2023-11-09 | -$144.72M derived: sum of 4 quarters · filed 2023-11-09 | ||
| 2021-12-31 | $1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$40.95M derived: sum of 2 quarters · filed 2023-03-09 | -$86.66M derived: sum of 3 quarters · filed 2023-03-09 | -$124.97M 10-K · filed 2023-03-09 | -$124.97M 10-K · filed 2023-03-09 | |
| 2021-09-30 | -$42.42M 10-Q · filed 2022-11-10 | -$88.13M derived: sum of 2 quarters · filed 2022-11-10 | -$126.44M 10-Q · filed 2022-11-10 | -$162.59M derived: sum of 4 quarters · filed 2022-11-10 | ||
| 2021-06-30 | -$45.70M 10-Q · filed 2022-11-10 | -$84.02M 10-Q · filed 2022-08-11 | -$120.17M derived: sum of 3 quarters · filed 2022-11-10 | -$154.58M derived: sum of 4 quarters · filed 2022-11-10 | ||
| 2021-03-31 | -$38.31M 10-Q · filed 2022-11-10 | -$74.46M derived: sum of 2 quarters · filed 2022-11-10 | -$108.88M derived: sum of 3 quarters · filed 2022-11-10 | -$139.30M derived: sum of 4 quarters · filed 2022-11-10 | ||
| 2020-12-31 | -$36.15M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$70.56M derived: sum of 2 quarters · filed 2022-03-10 | -$100.99M derived: sum of 3 quarters · filed 2022-03-10 | -$129.78M 10-K · filed 2022-03-10 | ||
| 2020-09-30 | -$34.41M 10-Q · filed 2021-11-09 | -$64.84M derived: sum of 2 quarters · filed 2021-11-09 | -$93.63M 10-Q · filed 2021-11-09 | -$117.24M derived: sum of 4 quarters · filed 2021-11-09 | ||
| 2020-06-30 | -$30.43M 10-Q · filed 2021-11-09 | -$59.21M 10-Q · filed 2021-08-12 | -$82.83M derived: sum of 3 quarters · filed 2021-11-09 | -$103.78M derived: sum of 4 quarters · filed 2021-11-09 | ||
| 2020-03-31 | -$28.78M 10-Q · filed 2021-11-09 | -$52.40M derived: sum of 2 quarters · filed 2021-11-09 | -$73.35M derived: sum of 3 quarters · filed 2021-11-09 | -$101.98M derived: sum of 4 quarters · filed 2021-11-09 | ||
| 2019-12-31 | -$23.61M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$44.57M derived: sum of 2 quarters · filed 2021-03-11 | -$73.19M derived: sum of 3 quarters · filed 2021-03-11 | -$86.53M 10-K · filed 2021-03-11 | -$86.50M 10-Q · filed 2020-08-20 | |
| 2019-09-30 | -$20.95M 10-Q · filed 2020-11-12 | -$49.58M derived: sum of 2 quarters · filed 2020-11-12 | -$62.91M 10-Q · filed 2020-11-12 | |||
| 2019-06-30 | -$28.63M 10-Q · filed 2020-11-12 | -$41.96M 10-Q · filed 2020-08-20 | ||||
| 2019-03-31 | -$13.33M 10-Q · filed 2020-11-12 |